Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Yeda discloses peptides for myasthenia gravis

Feb. 18, 1997

Inhibitors of cell adhesion disclosed by Tanabe

Feb. 18, 1997

Immunosuppressants discovered by Merck & Co.

Feb. 18, 1997

Abbott discloses nicotinic cholinergic channel modulators

Feb. 18, 1997

Adenosine kinase inhibitors prepared by Gensia

Feb. 18, 1997

Ortho synthesizes inhibitors of serine proteases

Feb. 18, 1997

COR Therapeutics discloses factor Xa inhibitors

Feb. 18, 1997

Apoptosis-regulating factor discovered

Feb. 17, 1997

Chiron prepares uPA inhibitors

Feb. 17, 1997

Human Genome Sciences discloses novel human polypeptide for cancer

Feb. 17, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
FB-7033 demonstrates efficacy in MASH management
BioWorld Science
17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...
Preclinical results support Actinium’s radioconjugate ATNM‑400 for NSCLC
BioWorld Science
At the recent meeting of the Society of Nuclear Medicine and Molecular Imaging, researchers from Actinium Pharmaceuticals Inc. presented preclinical efficacy data...
Bial-Portela discovers new OX1 receptor antagonists
BioWorld Science
Bial-Portela & Ca SA has patented new orexin OX1 receptor antagonists potentially useful for the treatment of anxiety disorders, depression, eating disorders,...
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...